International audienceBACKGROUND Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data on the utility of cardiovascular magnetic resonance (CMR) T1 and T2 mapping in ICI myocarditis are limited.OBJECTIVES This study sought to assess the value of CMR T1 and T2 mapping in patients with ICI myocarditis.METHODS In this retrospective study from an international registry of patients with ICI myocarditis, clinical and CMR findings (including T1 and T2 maps) were collected. Abnormal T1 and T2 were defined as 2 SD above site (vendor/field strength specific) reference values and a z-score was calculated for each patient. Major adverse cardiovascular events (MACE) were a composite of cardiovascular death, c...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...
International audienceBACKGROUND Myocarditis is a potentially fatal complication of immune checkpoin...
International audienceBACKGROUND Myocarditis is a potentially fatal complication of immune checkpoin...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data o...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data o...
BACKGROUND: Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) the...
AIMS: Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse ...
International audienceAims Myocarditis is a potentially fatal complication of immune checkpoint inhi...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
AimsMyocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse da...
Immune checkpoint inhibitors (ICIs) are a family of anticancer drugs in which the immune response el...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...
International audienceBACKGROUND Myocarditis is a potentially fatal complication of immune checkpoin...
International audienceBACKGROUND Myocarditis is a potentially fatal complication of immune checkpoin...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data o...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. Data o...
BACKGROUND: Myocarditis is a potentially fatal complication of immune checkpoint inhibitor (ICI) the...
AIMS: Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse ...
International audienceAims Myocarditis is a potentially fatal complication of immune checkpoint inhi...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
AimsMyocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse da...
Immune checkpoint inhibitors (ICIs) are a family of anticancer drugs in which the immune response el...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data e...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...
International audienceImmune checkpoint inhibitors (ICI) have constituted a paradigm shift in the ma...